The Beauty of Taiwan

         CorMedix - the anti-infective space



         CorMedix Inc. (NASDAQ:CRMD) Q2 2025 Earnings Call Transcript

         Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership

         Melinta goes bankrupt / Never let a good crisis go to waste

         Melinta Therapeutics and Cidara Therapeutics Announce Licensing Agreement to Commercialize Rezafungin in the U.S.

         Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (ReSPECT)

         Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

         A Medical Play With 'Exploding' Sales Is on My Radar

         Corporate Presentation September 2025

         CorMedix Inc. (CRMD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

         CRMD vs. MIRM: Which Specialized Biotech Stock is the Better Pick?